2031 年全外显子组测序市场报告(按细分市场、地域、动态、最新发展和战略见解)

  • Report Code : TIPRE00005519
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Whole Exome Sequencing Market Key Findings by 2031

Buy Now

整个外显子组测序市场规模预计将从 2023 年的 4.145 亿美元增至 2031 年的 14.578 亿美元。预计 2023-2031 年市场复合年增长率为 17.02%。人工智能和机器学习算法的结合以及使用全外显子组测序诊断和治疗癌症可能仍然是市场的主要趋势。

全外显子组测序市场分析

全外显子组测序是下一代技术,由于其优点而被广泛首选作为全基因组测序的替代品。由于整个测序技术减少了遗传学分析的时间和成本,因此也减少了药物配方试验和错误所花费的时间。下一代测序使人类群体之间的基因型和表型关系的分析获得了更高的结果,有助于开发用于药物开发的遗传信息。价格的大幅下降和技术的不断进步正在导致人们转向强调通过全外显子组测序进行药物开发。

全外显子组测序市场概述

外显子组测序是一种广泛使用的技术,它包含大约 85% 的变异或突变引起的疾病的分析。因此,它被广泛用于遗传疾病和群体遗传学等应用。据英国遗传疾病协会估计,在英国,近五分之一的儿童被诊断患有遗传疾病。它还允许研究人员访问受肿瘤影响区域的编码来诊断癌症。此外,正在进行各种计划来确保和实施精准医疗。例如,日本国家癌症中心的基因组测序和 TOP-GEAR 基因检测项目正在利用数据寻找治疗癌症的临床应用。除了这些项目之外,私营部门和学术机构也进行了合作,并正在开展 MASTER KEY 项目。该项目目前正在致力于优化罕见癌症的基因组医学。

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

全外显子组测序市场:Exome Sequencing Market:

全外显子组测序市场
  • Whole Exome Sequencing Market
    年均复合增长率(2023 - 2031)
    17.02%
  • 2023 年市场规模
    4.145 亿美元
  • 2031 年市场规模
    14.578 亿美元

市场动态

增长动力
  • 慢性病有效分子诊断的需求不断增长,促进了市场增长
未来的趋势
  • 药物发现中应用的增加推动了临床研究组织的需求
机会
  • 发展个性化医疗创造利润丰厚的机会

关键人物;主力;重要一员

  • 赛默飞世尔科技公司
  • 照明公司
  • Centogene公司
  • F.霍夫曼-拉罗氏股份公司
  • Psomagen, Inc.(前身为 Macrogen Corp.)
  • 加利福尼亚太平洋生物科学公司
  • 金唯智有限公司
  • Bio-Rad 实验室有限公司
  • 欧陆科技
  • 斯特拉托斯基因组学

区域概况

Whole Exome Sequencing Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Whole Exome Sequencing Market产品与服务
  • 系统
  • 套件
  • 服务
Whole Exome Sequencing Market技术
  • 测序合成
  • 离子半导体测序
  • 其他技术
  •  
Whole Exome Sequencing Market应用
  • 诊断
  • 药物发现与开发
  • 个性化医疗
  • 其他应用
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

全外显子组测序市场驱动因素和机遇

分子诊断需求不断增长,有利于市场增长

由于全外显子组测序的优点,它在常规实践中被用作诊断工具。该技术主要用于诊断遗传性疾病和癌症。全外显子组测序技术被认为是针对癫痫、神经病和其他遗传疾病等复杂疾病进行靶向治疗的理想选择。此外,全外显子组测序可以借助新一代测序在单次运行中对人类基因组中近 23,000 个基因进行完整分析。全外显子组测序在研究、诊断和临床领域具有优势。因此,全外显子组测序在分子诊断和临床诊断领域的广泛应用是全球全外显子组测序市场份额的主要驱动力。

个性化医疗的发展

下一代测序的进步正在引起人们对个性化医疗或精准医疗的关注。研究个体整个外显子组的能力使医疗专业人员能够根据每个患者独特的基因组成和疾病易感性定制治疗方案。这种个性化的医疗保健方法为更有效和有针对性的治疗提供了机会,从而改善患者的治疗结果。由于测序技术和数据分析工具的发展,全外显子组测序的经济性和可及性提高,因此在临床环境中得到了更广泛的应用。因此,由于人们越来越认识到个性化护理的好处,对全外显子组测序的需求不断增长,正在塑造医疗保健的未来。

全外显子组测序市场报告细分分析

有助于推导的关键部分整个外显子组测序市场分析包括产品和服务、技术和应用。

  • 根据产品和服务,整个外显子组测序市场分为系统、试剂盒和服务。测序服务、数据分析(生物信息学)服务和其他服务是服务细分领域的重要细分领域。套件细分市场在 2023 年占据最大的市场份额,预计在预测期内复合年增长率最高。
  • 按技术划分,市场分为离子半导体测序、合成测序和其他技术。合成测序领域在 2023 年占据最大市场份额,预计在预测期内复合年增长率最高。
  • 就应用而言,市场分为诊断、药物发现和开发、个性化医疗和其他应用。根据诊断,市场进一步分为癌症诊断、单基因(孟德尔)疾病诊断、单基因类型糖尿病诊断、艾滋病毒诊断和其他诊断。诊断细分市场到 2023 年将占据重要市场份额,预计在预测期内复合年增长率最高。

按地域划分的全外显子组测序市场份额分析

全外显子组测序市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美洲和中美洲。

北美市场占据主导地位。市场的增长主要受到镰状细胞病、地中海贫血等遗传性疾病发病率上升的影响。加拿大政府举措的增加可能会增加全国范围内的基因组活动。此外,政府还筹集了资金来支持该地区的基因组学研究。此外,墨西哥各地的增长机会不断增加,因为该国有潜力支持基因组研究,并且全球市场参与者在基因组学领域的存在是促成市场主导地位的因素。预计亚太地区未来几年将以最高的复合年增长率增长。

全外显子组测序市场报告范围

报告属性细节
2023年市场规模4.145 亿美元
2031 年市场规模14.578 亿美元
全球复合年增长率(2023 - 2031)17.02%
历史数据2021-2022
预测期2024-2031
涵盖的细分市场按产品和服务
  • 系统
  • 套件
  • 服务
按技术
  • 测序合成
  • 离子半导体测序
  • 其他技术
  •  
按申请
  • 诊断
  • 药物发现与开发
  • 个性化医疗
  • 其他应用
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 赛默飞世尔科技公司
  • 照明公司
  • Centogene公司
  • F.霍夫曼-拉罗氏股份公司
  • Psomagen, Inc.(前身为 Macrogen Corp.)
  • 加利福尼亚太平洋生物科学公司
  • 金唯智有限公司
  • Bio-Rad 实验室有限公司
  • 欧陆科技
  • 斯特拉托斯基因组学
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

全外显子组测序市场新闻和最新动态

整个外显子组测序市场是通过收集初级和二级研究后的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。以下列出了整个外显子组测序市场的一些进展:

  • Illumina Inc. 宣布其首款基于其新颖的 Illumina Complete Long Read 技术的产品可供订购。高性能、长读长人类全基因组测序分析——Illumina Complete Long Read Prep, Human——与该公司的 NovaSeq X Plus、NovaSeq X 和 NovaSeq 6000 测序系统兼容。它使用户可以在同一台 Illumina 仪器上访问长读和短读数据。 (来源:Illumina Inc.,新闻稿,2023 年 3 月)
  • 领先的群体基因组学公司 Helix 的 Helix 实验室平台已获得美国食品和药物管理局 (FDA) 的重新授权,该平台是一个覆盖约 20,000 个基因的全外显子组测序平台。此外,Helix 还获得了针对晚发性阿尔茨海默病的 Helix 遗传健康风险应用程序的 510(k) 许可,可在 Helix 实验室平台上作为非处方药使用。 (来源:Helix,新闻稿,2021 年 1 月)

全外显子组测序市场报告范围和交付成果

《全外显子组测序市场规模及预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

  • 全外显子组测序市场规模以及全球、区域和国家层面涵盖的所有关键细分市场的预测
  • 全外显子组测序市场趋势以及市场动态,例如驱动因素、限制因素和关键机遇
  • 详细的 PEST 和 SWOT 分析
  • 全外显子组测序市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及全外显子组测序市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the whole exome sequencing market in 2023?

North America region dominated the whole exome sequencing market in 2023.

What are the driving factors impacting the whole exome sequencing market?

Rising need for molecular diagnosis and increasing application in drug discovery are the most influential factors responsible for market growth.

Which are the leading players operating in the whole exome sequencing market?

Thermo Fisher Scientific Inc.; Illumina, Inc.; Centogene AG; F. Hoffmann-La Roche AG; Psomagen, Inc. (previously Macrogen Corp.); Pacific Biosciences of California, Inc.; GENEWIZ, Inc.; Bio-Rad Laboratories, Inc.; Eurofins Scientific; and Stratos Genomics are the key players in the whole exome sequencing market.

What would be the estimated value of the whole exome sequencing market by 2031?

The estimated value of the whole exome sequencing market accounted for US$ 1,457.8 million in 2031.

What is the expected CAGR of the whole exome sequencing market?

The CAGR for whole exome sequencing market accounted for 17.02% during 2023-2031.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..